Clover Biopharmaceuticals
Dr. Yang Li serves as Chief Technology Officer Senior at Clover. He brings many years of experience in biologic therapeutics process and product development. Prior to Clover, Dr. Li was the VP, CMC Head of Overland Pharma Shanghai China. Prior to that, Dr. Li held VP/CMC head, Senior Scientist, and Scientist positions at Lyvgen Biopharma, Celgene Corporation, and Bristol-Myers Squibb, respectively.
Dr. Yang Li obtained his Ph.D. degree in Bioengineering from Massachusetts Institute of Technology.
This person is not in any offices
Clover Biopharmaceuticals
2 followers
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.